Publications

  1. Osinaga E. Mucins. In: Encyclopedia of Cancer, 2nd Edition. M. Schwab (Ed.), Springer-Verlag GmbH, Heidelberg ISBN: 978-3-540-47648-1 (2008)
  2. Medeiros A, Chiribao ML, Ubillos L, Festari MF, Saldaña J; Robello C, Domínguez L; Calvete JJ and Osinaga E. Mucin-type O-glycosylation in Mesocestoides vogae. International Journal for Parasitology, v. 38 , p. 265-276, 2008. (Impact 1.129)
  3. Croci D, Cognoa I, Rumie Vittara N, Salvatierra E, Trajtenberg F, Podhajcer O, Osinaga E, Rabinovich G and Rivarola V. Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway. Journal of Cellular Biochemistry, v. 105 , p. 381-390, 2008. (Impact 3.381)
  4. Gomes J, Marcos NT, Berois N, Osinaga E, Magalhães A, Pinto-de-Sousa J, Almeida R, Gärtner F and Reis CA. Expression of UDP-N-acetyl-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma. J. Histochem. Cytochem. 57:79-86, 2009 (Impact 2.35)
  5. Robles A, Medeiros A, Berois N, Balter H, Pauwels E and Osinaga E. In site interaction evaluation of Tn density by inhibition/competition assays. Nuclear Medicine and Biology (2010, in press)
  6. Hill M, Mazal D, Biron V, Pereira L, Ubillos L, Berriel E, Ahmed H, Freire T, Rondán M, Vasta GR, Liu FT, Iglesias MM and Osinaga E. A novel clinically-relevant animal model to study galectin-3 and its ligands during colon carcinogenesis. J. Histochem. Cytochem. (2010, in press)

Patents

  • Hubert-Haddad P, Amigorena S, Sastre-Garau X, Osinaga E, Pritsch O, Oppezzo P, Perez F, Moutel S. An antibody specific for the Tn antigen for the treatment of cancer. European Patent WO/2009/007222 (2009)